Heartline·Cardiovascular desk November 13, 2026 · 56 plain-English notes

Evidence-led notes on the heart, the vessels and the habits that shape both.

Lipids & Statins · Note 16

Ditching Primary Prevention Statins in Old Age? Technically 'Safe' With Caveats

In the STREAM randomised trial, long-time statin users over 70 were arguably fine stopping therapy, but longer-term cardiovascular safety was less reassuring and quality of life did not improve.

MedPage Today Cardiology November 8, 2026 RSS metadata basis
Abstract heartbeat trace artwork
Schematic artwork — not clinical data. The trace is generated for layout, not measurement.

The STREAM trial asked a question many older patients raise: if I have taken a statin for years and have never had a heart attack, do I still need it? Randomising that question is the only way to separate the drug's effect from the healthy-adherer bias that shapes observational data.

Participants over 70 who had used statins for a long time were assigned to continue or stop. The short-term safety picture was acceptable, but the longer-term signal for cardiovascular events was not reassuring, and stopping did not produce a measurable quality-of-life gain. That combination matters: a strategy needs a benefit to justify itself.

The trial does not settle the care of every older adult. It does suggest that deprescribing should be framed as a trade-off rather than a liberation. The original coverage and the trial publication should be consulted for event rates, follow-up duration and the specific population enrolled.

Why it mattersSTREAM randomised continuing versus stopping statins in people over 70.

Keep in mind

  • Short-term safety was acceptable, but longer-term event data were less reassuring.
  • Quality of life did not improve after stopping.

Source and reuse

This is an independent editorial summary written for Heartline. It is not a verbatim reproduction and does not reproduce paywalled text. Reporting, data and quotations belong to MedPage Today Cardiology. Read the original at the link provided.

Metadata basis: the publisher’s public RSS feed and the abstract it exposes. Where the full article could not be accessed, this note is explicitly metadata-based and limited to what the feed disclosed. It is not medical advice.

Read the original at MedPage Today Cardiology →